Oncology nurse April Fowler shares her personal stage 4 cancer journey, reflecting on clinical empathy, patient advocacy, and oncology endurance.
|Videos|June 20, 2016
Mei R. Fu, PhD, Offers Strategies to Manage Pain after Breast Cancer Treatment
Advertisement
Dr. Mei R. Fu offers strategies to manage daily or periodic pain after breast cancer treatment and explores the reasons some women may experience it in this recording of her webinar at SHARE, “Persistent and Intermittent Pain After Breast Cancer Treatment.” Watch and listen below. Mei R. Fu, PhD, RN, ACNS-BC, FAAN, is Associate Professor College of Nursing NYU.
Advertisement
Related to this article
A nurse-led support program significantly reduces death anxiety in women with breast cancer on hormonal therapy, study finds.
FDA approves imlunestrant plus abemaciclib for ESR1-mutated, ER-positive, HER2-negative advanced or metastatic breast cancer after endocrine therapy.
Patients often use AI to read test results, but AI can misinterpret data and cause panic. Learn why human context remains critical.
Dr. Wendy Harpham reflects on her journey as a physician and patient, emphasizing precise clinical communication in oncology care.
FDA approves pirtobrutinib for untreated CLL/SLL without 17p deletion based on BRUIN CLL-313 data. Read key nursing safety takeaways.
Most oral blood cancer drug prescriptions were first rejected by insurers, and fill rates fell sharply when out-of-pocket costs topped $175.
At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Pirtobrutinib for Untreated CLL/SLL
2
Prior Authorization, Costs Limit Access to Oral Blood Cancer Drugs
3
Balancing Treatment Efficacy and Quality of Life in Metastatic Triple-Negative Breast Cancer
4
Tailoring Toxicity Monitoring for ADCs in Metastatic Triple-Negative Breast Cancer
5